Monitor for additional insider selling in next 30 days; consider as potential early signal of waning confidence, especially given participation by C-suite executives.
VIR drugs
VIR drug pipeline →How the stock moved after the report
BEARISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Feb 24 $9.49entry
- T+1 · 9mo ago +5.37%α +4.54% · $10.00
- T+5 · 9mo ago −6.11%α −5.08% · $8.91
- T+20 · 8mo ago −9.69%α −4.71% · $8.57
- T+60 · 6mo ago −10.12%α −16.86% · $8.53
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Three corporate insiders at Vir Biotechnology sold shares in the past seven days, including two executives who sold a combined $153,084 worth of stock. All transactions were open-market sales at prevailing prices, with total proceeds of $360,269.
Key Financial Metrics
Key Facts
- EVP and Chief Medical Officer Mark Eisner sold 1,889 shares for $18,549.98 at $9.82 per share on 2026-02-25
- EVP Vanina de Verneuil sold 13,700 shares for $134,534 at $9.82 per share on 2026-02-25
- Vicki L. Sato, a director, sold 21,800 shares for $207,185.02 at $9.5039 per share on 2026-03-02
- Total open-market sales in cluster: $360,269 across three insiders
- Sales represent approximately 0.028% of company's $1.3B market cap
Financial Impact
$360,269 in net insider selling over 7 days
Risk Factors
- Insider selling may signal lack of confidence in near-term prospects
- Concentration of sales among senior executives increases concern level
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (3 trades, 7d window) | cluster-VIR-1772557839249 |
Track record
36 reports on VIR
3 of 7 bullish or bearish reports moved the stock their way by T+5. Best: +29.79% at T+5 after the Nov 6, 2026 report. 4 of 8 went positive at some point.
Filters
- Nov 16, 2026today 424B5 Bearish 5/10 Entry price pending
- Nov 13, 20263d ago 8-K Bearish 5/10 Entry $9.92 Now $9.58 +3.43% settles Nov 23
- Nov 12, 20264d ago 424B5 Bearish 5/10 Entry $9.96 Now $9.58 +3.82% settles Nov 20
- Nov 12, 20264d ago S-3ASR Neutral 3/10 Entry $9.96 Now $9.58 −3.82% settles Nov 20
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $13.15 Now $9.58 −27.15% settles Nov 17
- Nov 9, 20267d ago 8-K Bullish 6/10 Entry $13.65 to $9.58 Now $9.58 −29.79% ▼ −29.79% −28.10% vs SPY
- Nov 6, 202610d ago SC 13D/A Bearish 5/10 Entry $13.65 to $9.58 Now $9.58 +29.79% ▲ +29.79% +28.10% vs SPY
- Nov 4, 202612d ago 8-K Neutral 5/10 Entry $11.02 to $12.12 Now $9.58 −13.07% ▲ +9.98% +6.69% vs SPY
- Nov 3, 202613d ago 144 Neutral 2/10 Entry $11.22 to $13.15 Now $9.58 −14.62% ▲ +17.20% +17.79% vs SPY
- Nov 2, 202614d ago 144 Neutral 1/10 Entry $11.00 to $13.65 Now $9.58 −12.91% ▲ +24.05% +23.97% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers